These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 3141321

  • 1. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
    Teicher BA, Herman TS, Rose CM.
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1187-92. PubMed ID: 3141321
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
    Teicher BA, Holden SA, Northey D, Dewhirst MW, Herman TS.
    Int J Radiat Oncol Biol Phys; 1993 Apr 30; 26(1):103-9. PubMed ID: 8482616
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
    Rockwell S, Mate TP, Irvin CG, Nierenburg M.
    Int J Radiat Oncol Biol Phys; 1986 Aug 30; 12(8):1315-8. PubMed ID: 3093416
    [Abstract] [Full Text] [Related]

  • 6. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas.
    Martin DF, Porter EA, Fischer JJ, Rockwell S.
    Radiat Res; 1987 Oct 30; 112(1):45-53. PubMed ID: 3116598
    [Abstract] [Full Text] [Related]

  • 7. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
    Lee I, Levitt SH, Song CW.
    Radiat Res; 1987 Oct 30; 112(1):173-82. PubMed ID: 3116597
    [Abstract] [Full Text] [Related]

  • 8. Effects of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DA.
    Teicher BA, Rose CM.
    Int J Radiat Oncol Biol Phys; 1986 Aug 30; 12(8):1311-3. PubMed ID: 3093415
    [Abstract] [Full Text] [Related]

  • 9. Radiosensitization of murine tumors by Fluosol-DA 20%.
    Lee I, Levitt SH, Song CW.
    Radiat Res; 1990 Jun 30; 122(3):275-9. PubMed ID: 2113298
    [Abstract] [Full Text] [Related]

  • 10. Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
    Teicher BA, Herman TS, Tanaka J, Dezube B, Pardee A, Frei E.
    Cancer Chemother Pharmacol; 1991 Jun 30; 28(1):45-50. PubMed ID: 1904012
    [Abstract] [Full Text] [Related]

  • 11. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
    Teicher BA, Bernal SD, Holden SA, Cathcart KN.
    Cancer Chemother Pharmacol; 1988 Jun 30; 21(4):281-5. PubMed ID: 3131032
    [Abstract] [Full Text] [Related]

  • 12. Preclinical studies of a perfluorochemical emulsion as an adjunct to radiotherapy.
    Rockwell S, Irvin CG, Kelley M.
    Int J Radiat Oncol Biol Phys; 1988 Oct 30; 15(4):913-20. PubMed ID: 3141320
    [Abstract] [Full Text] [Related]

  • 13. Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma.
    Teicher BA, Holden SA, Rose CM.
    Int J Cancer; 1986 Aug 15; 38(2):285-8. PubMed ID: 3089945
    [Abstract] [Full Text] [Related]

  • 14. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA, Holden SA, Jacobs JL.
    Cancer Res; 1987 Jan 15; 47(2):513-8. PubMed ID: 3098413
    [Abstract] [Full Text] [Related]

  • 15. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
    Holden SA, Teicher BA, McIntosh NL, Rose CM.
    Anticancer Res; 1987 Jan 15; 7(3 Pt B):385-90. PubMed ID: 3115174
    [Abstract] [Full Text] [Related]

  • 16. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo.
    Kim GE, Song CW.
    Cancer Chemother Pharmacol; 1989 Jan 15; 25(2):99-102. PubMed ID: 2513138
    [Abstract] [Full Text] [Related]

  • 17. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
    Teicher BA, Herman TS, Holden SA, Jones SM.
    J Natl Cancer Inst; 1989 Jun 21; 81(12):929-34. PubMed ID: 2525198
    [Abstract] [Full Text] [Related]

  • 18. Synergistic effect of perfluorochemicals on BCNU chemotherapy. Experimental study in a 9L rat brain-tumor model.
    Kuwamura K, Kokunai T, Tamaki N, Matsumoto S.
    J Neurosurg; 1982 Oct 21; 57(4):467-71. PubMed ID: 7108595
    [Abstract] [Full Text] [Related]

  • 19. Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation.
    Holden SA, Herman TS, Teicher BA.
    Radiother Oncol; 1990 May 21; 18(1):59-70. PubMed ID: 2113698
    [Abstract] [Full Text] [Related]

  • 20. A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
    Teicher BA, Holden SA, Ara G, Ha CS, Herman TS, Northey D.
    J Cancer Res Clin Oncol; 1992 May 21; 118(7):509-14. PubMed ID: 1624542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.